清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Pharmacotherapy for the Prevention of Chronic Pain after Surgery in Adults: An Updated Systematic Review and Meta-analysis

医学 荟萃分析 药物治疗 慢性疼痛 梅德林 内科学 重症监护医学 物理疗法 政治学 法学
作者
Meg Carley,Luis Enrique Chaparro,Manon Choinière,Henrik Kehlet,R Andrew Moore,E Kerkhof,Ian Gilron
出处
期刊:Anesthesiology [Lippincott Williams & Wilkins]
卷期号:135 (2): 304-325 被引量:158
标识
DOI:10.1097/aln.0000000000003837
摘要

Background Chronic postsurgical pain can severely impair patient health and quality of life. This systematic review update evaluated the effectiveness of systemic drugs to prevent chronic postsurgical pain. Methods The authors included double-blind, placebo-controlled, randomized controlled trials including adults that evaluated perioperative systemic drugs. Studies that evaluated same drug(s) administered similarly were pooled. The primary outcome was the proportion reporting any pain at 3 or more months postsurgery. Results The authors identified 70 new studies and 40 from 2013. Most evaluated ketamine, pregabalin, gabapentin, IV lidocaine, nonsteroidal anti-inflammatory drugs, and corticosteroids. Some meta-analyses showed statistically significant—but of unclear clinical relevance—reductions in chronic postsurgical pain prevalence after treatment with pregabalin, IV lidocaine, and nonsteroidal anti-inflammatory drugs. Meta-analyses with more than three studies and more than 500 participants showed no effect of ketamine on prevalence of any pain at 6 months when administered for 24 h or less (risk ratio, 0.62 [95% CI, 0.36 to 1.07]; prevalence, 0 to 88% ketamine; 0 to 94% placebo) or more than 24 h (risk ratio, 0.91 [95% CI, 0.74 to 1.12]; 6 to 71% ketamine; 5 to 78% placebo), no effect of pregabalin on prevalence of any pain at 3 months (risk ratio, 0.88 [95% CI, 0.70 to 1.10]; 4 to 88% pregabalin; 3 to 80% placebo) or 6 months (risk ratio, 0.78 [95% CI, 0.47 to 1.28]; 6 to 68% pregabalin; 4 to 69% placebo) when administered more than 24 h, and an effect of pregabalin on prevalence of moderate/severe pain at 3 months when administered more than 24 h (risk ratio, 0.47 [95% CI, 0.33 to 0.68]; 0 to 20% pregabalin; 4 to 34% placebo). However, the results should be interpreted with caution given small study sizes, variable surgical types, dosages, timing and method of outcome measurements in relation to the acute pain trajectory in question, and preoperative pain status. Conclusions Despite agreement that chronic postsurgical pain is an important topic, extremely little progress has been made since 2013, likely due to study designs being insufficient to address the complexities of this multifactorial problem. Editor’s Perspective What We Already Know about This Topic What This Article Tells Us That Is New
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
cdercder应助科研通管家采纳,获得10
1秒前
1秒前
cdercder应助科研通管家采纳,获得10
1秒前
cdercder应助科研通管家采纳,获得10
1秒前
1秒前
1秒前
SciGPT应助科研通管家采纳,获得10
1秒前
cdercder应助科研通管家采纳,获得10
1秒前
8秒前
黑猫老师完成签到 ,获得积分10
18秒前
cdercder应助li采纳,获得10
27秒前
满月寂照发布了新的文献求助10
30秒前
32秒前
youyou2679完成签到,获得积分10
37秒前
小蘑菇应助满月寂照采纳,获得10
40秒前
王占帅完成签到,获得积分10
44秒前
1分钟前
1分钟前
河鲸完成签到 ,获得积分10
1分钟前
四氧化三铁完成签到,获得积分10
1分钟前
科研通AI6.4应助xxx采纳,获得10
1分钟前
1分钟前
2分钟前
充电宝应助科研通管家采纳,获得10
2分钟前
cdercder应助科研通管家采纳,获得30
2分钟前
2分钟前
2分钟前
2分钟前
宋相甫发布了新的文献求助20
2分钟前
cdercder应助科研通管家采纳,获得30
2分钟前
无悔完成签到 ,获得积分0
2分钟前
慕青应助androabo采纳,获得30
2分钟前
2分钟前
在水一方应助宋相甫采纳,获得10
2分钟前
xxx发布了新的文献求助10
2分钟前
2分钟前
宋相甫发布了新的文献求助10
2分钟前
宋相甫完成签到,获得积分10
3分钟前
xxx完成签到,获得积分10
3分钟前
3分钟前
高分求助中
The Graphene Handbook (2019 Edition) 800
IEST-RP-CC018: Cleanroom Cleaning and Sanitization: Operating and Monitoring Procedures 600
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
久松真一著作集〈第5巻〉禅と芸術 500
Fundamentals of Modern Mathematics: A Practical Review (Dover Books on Mathematics) 500
Cold War Transcended: Australia's China Policy, 1949-1990 470
Comprehensive Organic Synthesis 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6592977
求助须知:如何正确求助?哪些是违规求助? 8364265
关于积分的说明 17906515
捐赠科研通 5741841
什么是DOI,文献DOI怎么找? 2951927
邀请新用户注册赠送积分活动 1927226
关于科研通互助平台的介绍 1818553